Cargando…
Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
Autores principales: | Deme, Daniel, Kovacs, Sandor, Telekes, Andras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159149/ https://www.ncbi.nlm.nih.gov/pubmed/35665408 http://dx.doi.org/10.3389/pore.2022.1610517 |
Ejemplares similares
-
Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
por: Deme, Daniel, et al.
Publicado: (2022) -
A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer
por: Zeng, Jianmin, et al.
Publicado: (2022) -
Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
por: Li, Jin-Jin, et al.
Publicado: (2022) -
Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022) -
Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry
por: Kenessey, István, et al.
Publicado: (2022)